Insider Transactions in Q2 2022 at Tandem Diabetes Care Inc (TNDM)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 06
2022
|
Peyton R Howell Director |
BUY
Open market or private purchase
|
Direct |
2,000
+13.72%
|
$148,000
$74.86 P/Share
|
|
May 06
2022
|
Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
2,000
+11.0%
|
$150,000
$75.76 P/Share
|
|
May 05
2022
|
Christopher J Twomey Director |
SELL
Open market or private sale
|
Indirect |
248
-2.09%
|
$27,528
$111.73 P/Share
|
|
May 05
2022
|
Christopher J Twomey Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
373
+3.03%
|
$27,229
$73.73 P/Share
|
|
May 02
2022
|
Rebecca B Robertson Director |
SELL
Open market or private sale
|
Direct |
1,500
-67.77%
|
$144,000
$96.58 P/Share
|
|
May 02
2022
|
Rebecca B Robertson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$51,000
$34.0 P/Share
|
|
Apr 01
2022
|
David B Berger EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,000
-17.49%
|
$117,000
$117.88 P/Share
|
|
Apr 01
2022
|
David B Berger EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+14.89%
|
$18,000
$18.86 P/Share
|